News
MODULATING DNA DAMAGE RESPONSES TO CURE CANCER
Contact Us
Breakpoint Therapeutics GmbH
Essener Bogen 7
22419 Hamburg (Germany)
Telefon: +49 40 56081 180
E-mail: info@breakpointtx.com
Impressum
Registergericht: Hamburg
Registernummer: HRB 155717
Umsatzsteuer-Identifikationsnummer: DE 324 797 830
Geschäftsführer / Managing Directors
Dr. Daniel Speidel and Jonathan Hollick
Breakpoint To Present At LSX Inv€$tival Showcase
Breakpoint’s Managing Director Jon Hollick will present a company overview at the LSX Inv€$tival Showcase in London on November 13, 2023.
Breakpoint To Present At BIO Investor Forum
Breakpoint’s Managing Director Daniel Speidel will present a company overview at BIO Investor Forum in San Francisco on October 18, 2023. 10:00am, Franciscan C.
Breakpoint To Present At BIO International Convention 2023
Breakpoint’s Managing Director Daniel Speidel will present a company overview at BIO International Convention in Boston on June 7, 2023. 12:15pm, Session Room 104A.